Waks Featured in American Lawyer About His Work Helping Establish Encore Live’s Drive-In Concert Series
25 August 2020
Partner Larry Waks was quoted in The American Lawyer article, “Meet the Lawyer Who Helped Make Drive-In Theaters Cool Again,” about his work on behalf of Foley client Encore Live and its “Drive-In Nights” theater concert series. Encore Live is a full-service event production company based in the Dallas-Fort Worth area that plans, organizes and executes events all over the country.
Waks spoke with the publication about how he was able to help facilitate the streaming and prerecorded concerts and content that is now leading a resurgence for the approximately 400 drive-in theaters left in the United States.
“They [Encore Live] came up with this idea … as there are no concerts or private gatherings, but maybe we can get them [people] to go to drive-in theaters in their cars,” Waks said. “The first concert they produced was Garth Brooks. It was opportunistic in a positive way. For musicians, there is no touring these days. So, we thought, let’s get them into a studio, Nashville or L.A., which has gotten more difficult.”
The Foley team was led by Waks and Partner Glenn Singleton and included Partners Mike Dubner, Mike Donohue, James Howard and Lynn Gandhi, as well as Associates Matt Kiel, Bryce Morgan and Randy Pummill.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”